Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,514.00
Bid: 12,512.00
Ask: 12,514.00
Change: -76.00 (-0.60%)
Spread: 2.00 (0.016%)
Open: 12,626.00
High: 12,646.00
Low: 12,488.00
Prev. Close: 12,590.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CORRECTED-UPDATE 5-Japan approves more COVID-19 vaccines, expands state of emergency

Fri, 21st May 2021 04:06

(Corrects AstraZeneca comment)

By Chang-Ran Kim

TOKYO, May 21 (Reuters) - Japan expanded a state of
emergency to cover the southern island of Okinawa on Friday, as
authorities approved two more coronavirus vaccines to speed a
lagging inoculation campaign.

The newly approved vaccines, from Moderna Inc and
AstraZeneca PLC, will join the one co-developed by
Pfizer Inc and BioNTech SE in a vaccination
drive that began in mid-February.

Earlier media said the government would hold off on the use
of AstraZeneca's vaccine because of concerns over blood clots
and bleeding in some. The company said it was aware of the
government's decision that its vaccine would not be immediately
used.

"We'll do our utmost in working to ensure that all elderly
people who seek vaccinations can get their two shots by the end
of July," Economy Minister Yasutoshi Nishimura, who is leading
the coronavirus response effort, told reporters.

Japan has vaccinated just 4.1% of its population, according
to Reuters' global tracker https://tmsnrt.rs/3vbj5CE, the
slowest rate among the world's larger, rich countries.

In contrast to some other Group of Seven (G7) nations that
are beginning to end pandemic-busting lockdown measures, much of
Japan remains under emergency curbs amid a fourth wave of
infections.

On Friday, the government added Okinawa to its list of nine
prefectures placed under the strictest emergency measures. They
include Tokyo, where the Olympic Games are due to start in about
two months.

JAPAN INC, PUBLIC FEARS OVER OLYMPICS

Fears that the Olympics would turn into a super-spreader
event have persisted, ensuring opposition by the majority of the
public to holding the Games this year.

A Reuters corporate survey https://jp.reuters.com/article/us-olympics-2020-japan-companies-poll/fretting-about-covid-most-japan-firms-say-olympics-should-be-cancelled-or-postponed-reuters-poll-idUSKCN2D12SZ
published on Friday showed nearly 70% of Japanese firms also
want the Games either cancelled or postponed.

The state of emergency for Okinawa would run for about a
month, from Sunday through June 20, Prime Minister Yoshihide
Suga said, beyond the May 31 end-point of the other nine.

It is the third consecutive week that Japan is expanding the
state of emergency. With about 695,000 infections and 12,000
deaths, Japan is finding its medical system increasingly
strained by a spike in more infectious variants.

With the Olympics starting on July 23, Tokyo is under
particular pressure to cut infections and the strain on the
medical system and emerge from the emergency on schedule this
month.

After a 30-minute meeting with Suga on Friday, Tokyo
Governor Yuriko Koike said she sought vaccine supplies for the
capital, which begins mass vaccinations next week.

The two agreed to work towards a "safe and secure" Olympics
this summer, they later told reporters.
(Reporting by Chang-Ran Kim; Additional reporting by Rocky
Swift, Ritsuko Ando and Ju-Min Park; Editing by Christopher
Cushing and Clarence Fernandez)

More News
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more
26 Dec 2023 21:26

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 21:00

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 19:41

Wall Street gains on final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
22 Dec 2023 08:47

AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone"

(Alliance News) - AstraZeneca PLC and Ionis Pharmaceuticals Inc on Friday celebrated the news that their drug eplontersen was approved by the US Food & Drug Administration.

Read more
22 Dec 2023 07:50

LONDON BRIEFING: UK on brink of recession as economy contracts in Q3

(Alliance News) - Stocks in London are likely to open lower on Friday, with investors feeling frosty ahead of a US inflation print this afternoon, amid sobering UK economic growth data.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.